(Q27852990)

23

0 references

Alberto Bardelli

22

0 references

Alexander Eggermont

24

Alexander M M Eggermont

0 references

Caroline Robert

6

Caroline Robert

0 references

Chong Sun

Chong Sun

1

0 references

Stephan Vagner

Stephan Vagner

16

0 references

René Bernards

Rene Bernards

25

0 references

Christian U Blank

8

Christian Blank

0 references

Sebastijan Hobor

12

Sebastijan Hobor

0 references

Davide Zecchin

11

Davide Zecchin

0 references

author name string

Liqin Wang

2

0 references

Sidong Huang

3

0 references

Guus J J E Heynen

4

0 references

Anirudh Prahallad

5

0 references

John Haanen

7

0 references

Jelle Wesseling

9

0 references

Stefan M Willems

10

0 references

Prashanth K Bajpe

13

0 references

Cor Lieftink

14

0 references

Christina Mateus

15

0 references

Wipawadee Grernrum

17

0 references

Ingrid Hofland

18

0 references

Andreas Schlicker

19

0 references

Lodewyk F A Wessels

20

0 references

Roderick L Beijersbergen

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)

21

0 references

language of work or name

English

0 references

publication date

3 April 2014

0 references

published in

Nature

0 references

volume

508

0 references

page(s)

118-22

0 references

issue

7494

0 references

cites work

1 reference

12 December 2020

EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib

1 reference

12 December 2020

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

1 reference

12 December 2020

Improved survival with MEK inhibition in BRAF-mutated melanoma

1 reference

12 December 2020

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

1 reference

12 December 2020

Frequent mutations in the MITF pathway in melanoma

1 reference

12 December 2020

Mutations of the BRAF gene in human cancer

1 reference

12 December 2020

Successful rechallenge in two patients with BRAF-V600-mutant melanoma who experienced previous progression during treatment with a selective BRAF inhibitor

1 reference

12 December 2020

MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling

1 reference

12 December 2020

From genes to drugs: targeted strategies for melanoma

1 reference

12 December 2020

Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance

1 reference

12 December 2020

Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation

1 reference

12 December 2020

New tools for functional mammalian cancer genetics

1 reference

12 December 2020

Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling

1 reference

12 December 2020

PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells

1 reference

12 December 2020

A public genome-scale lentiviral expression library of human ORFs

1 reference

12 December 2020

Systematic identification of genomic markers of drug sensitivity in cancer cells

1 reference

12 December 2020

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

1 reference

12 December 2020

Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome

1 reference

12 December 2020

ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome

1 reference

12 December 2020

c-Jun regulates eyelid closure and skin tumor development through EGFR signaling

1 reference

12 December 2020

Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma

1 reference

12 December 2020

Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription

1 reference

12 December 2020

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

1 reference

12 December 2020

DNA topoisomerase I is a cofactor for c-Jun in the regulation of epidermal growth factor receptor expression and cancer cell proliferation

1 reference

12 December 2020

Activator protein-1 mediates induced but not basal epidermal growth factor receptor gene expression.

1 reference

12 December 2020

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.

1 reference

12 December 2020

BRAFE600-associated senescence-like cell cycle arrest of human naevi

1 reference

12 December 2020

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

1 reference

12 December 2020

Identifiers

DOI

10.1038/NATURE13121

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

744515

1045315782

0 references

744515

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference